PGAP1
Basic information
Region (hg38): 2:196833004-196927796
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal recessive 42 (Strong), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- autosomal recessive spastic paraplegia type 67 (Supportive), mode of inheritance: AR
- intellectual disability, autosomal recessive 42 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 24784135 |
ClinVar
This is a list of variants' phenotypes submitted to
- Intellectual_disability,_autosomal_recessive_42 (296 variants)
- Inborn_genetic_diseases (108 variants)
- not_provided (72 variants)
- Hereditary_spastic_paraplegia (29 variants)
- not_specified (23 variants)
- PGAP1-related_disorder (6 variants)
- See_cases (3 variants)
- Neurodevelopmental_disorder (2 variants)
- Cerebral_visual_impairment_and_intellectual_disability (2 variants)
- High_myopia (1 variants)
- Intellectual_disability,_autosomal_recessive_58 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGAP1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024989.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 68 | 3 | 75 | |
| missense | 178 | 16 | 194 | |||
| nonsense | 5 | 12 | 17 | |||
| start loss | 0 | |||||
| frameshift | 9 | 4 | 1 | 14 | ||
| splice donor/acceptor (+/-2bp) | 6 | 5 | 5 | 16 | ||
| Total | 20 | 22 | 187 | 84 | 3 |
Highest pathogenic variant AF is 0.000017355129
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PGAP1 | protein_coding | protein_coding | ENST00000354764 | 27 | 94793 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125689 | 0 | 59 | 125748 | 0.000235 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.26 | 379 | 455 | 0.834 | 0.0000221 | 5990 |
| Missense in Polyphen | 95 | 131.68 | 0.72145 | 1727 | ||
| Synonymous | 0.799 | 146 | 159 | 0.919 | 0.00000778 | 1729 |
| Loss of Function | 3.89 | 22 | 52.4 | 0.420 | 0.00000244 | 711 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000456 | 0.000442 |
| Ashkenazi Jewish | 0.000399 | 0.000397 |
| East Asian | 0.000280 | 0.000272 |
| Finnish | 0.000234 | 0.000231 |
| European (Non-Finnish) | 0.000233 | 0.000229 |
| Middle Eastern | 0.000280 | 0.000272 |
| South Asian | 0.000245 | 0.000196 |
| Other | 0.000519 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in inositol deacylation of GPI-anchored proteins. GPI inositol deacylation may important for efficient transport of GPI-anchored proteins from the endoplasmic reticulum to the Golgi (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 42 (MRT42) [MIM:615802]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:24482476, ECO:0000269|PubMed:24784135}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Intolerance Scores
- loftool
- 0.219
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.86
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.334
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Zebrafish Information Network
- Gene name
- pgap1
- Affected structure
- ceratobranchial cartilage
- Phenotype tag
- abnormal
- Phenotype quality
- shortened
Gene ontology
- Biological process
- GPI anchor metabolic process;endoplasmic reticulum to Golgi vesicle-mediated transport;sensory perception of sound;embryonic pattern specification;anterior/posterior axis specification;protein transport;myo-inositol transport;attachment of GPI anchor to protein;forebrain regionalization;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- nuclease activity;hydrolase activity, acting on ester bonds;phosphoric ester hydrolase activity;phosphatidylinositol deacylase activity